Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 42,650
+700 (1.67%)
At close: Dec 19, 2025
22.56% (1Y)
| Market Cap | 2.17T |
| Revenue (ttm) | 154.05B |
| Net Income (ttm) | 2.31B |
| Shares Out | 50.78M |
| EPS (ttm) | 45.51 |
| PE Ratio | 937.43 |
| Forward PE | 299.55 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 470,526 |
| Average Volume | 1,121,408 |
| Open | 42,500 |
| Previous Close | 41,950 |
| Day's Range | 41,650 - 43,500 |
| 52-Week Range | 24,000 - 57,100 |
| Beta | 0.75 |
| RSI | 45.24 |
| Earnings Date | Mar 6, 2026 |